AC Immune SA (ACIU)

NASDAQ

$2.14

-$0.12

(-5.31%)

Pre-Market

AC Immune SA (ACIU) Live Price Chart

Last updated: ⁦2026-11-13 12:18:20⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

AC Immune SA (ACIU) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $2.14, with a market capitalization of $212.77M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $2.02 to $3.90. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$212.77M
Open	$2.21
Day's High	$2.26
Day's Low	$2.13
Previous Close	$2.26
Volume	117.24K
Average Volume	199.57K
P/E Ratio	--
52-Week High	$3.90
52-Week Low	$2.02
Dividend Yield	--
Earnings Date	--

AC Immune SA (ACIU) Pre-Market Stock Price

AC Immune SA (ACIU) is trading at $2.32 in pre-market trading as of 2026-11-13 00:31:00, up 2.61% ($0.06) from the previous close of $2.26

Pre-market trading shows how investors are pricing ACIU before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.

AC Immune SA (ACIU) 7-Day Stock Price Change

Over the past seven days, AC Immune SA (ACIU) moved from $2.29 to $2.14, representing a decline of 6.55% ($0.15).

The stock traded between $2.02 and $2.55 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 233.44 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

ACIU 52-Week Price Position

Position in Range: 6.6%

52W Low$2.02

52W High$3.90

ACIU is currently trading at $2.14, placing it 6.6% of the way from its 52-week low of $2.02 to its 52-week high of $3.90. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is AC Immune SA (ACIU)?

AC Immune SA is a clinical stage biopharmaceutical company advancing a portfolio of programs strategically focused on pioneering Precision Medicine for neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The company has one segment. The company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.

AC Immune SA Information

Employees	122
Exchange	NASDAQ
Company Website	https://www.acimmune.com

ACIU News

Latest news related to AC Immune SA and ACIU stock.

Massive2026/11/12
Here's Why You Should Add AURA Stock to Your Portfolio Now
Aura Biosciences completed enrollment and dosing in its phase III CoMpass study evaluating bel-sar for early choroidal melanoma treatment. Top-line data is expected in the second half of 2027. If successful, bel-sar could become the first FDA-approved frontline vision-preserving therapy for this indication. The company is also exploring bel-sar for choroidal metastases and ocular surface cancers, with updates expected in Q1 2027. AURA shares have risen 39.6% year-to-date.
Read Full Article
Massive2026/11/12
Zoetis' Cytopoint Plus Gets USDA License for 75-Day Canine Itch Relief
Zoetis announced USDA approval for Cytopoint Plus, a monoclonal antibody therapy providing 75 days of relief from allergic itch in dogs. The extended dosing interval is approximately 1.5 times longer than existing mAb options, expanding Zoetis' canine dermatology portfolio alongside Cytopoint, Apoquel, and Apoquel Chewable. Market uptake will depend on pricing, veterinary recommendations, and real-world performance.
Read Full Article
Massive2026/11/11
BEAM Stock Falls 7% Despite Meeting Primary Endpoints in SCD Study
Beam Therapeutics reported positive top-line results from its BEACON study for risto-cel, a gene-editing therapy for sickle cell disease, achieving primary efficacy and safety endpoints with patients demonstrating freedom from severe vaso-occlusive crises for at least 12 consecutive months. The company plans to submit a biologics license application to the FDA by end of 2026, potentially marking the first commercial product approval for a base-editing therapy. Despite the encouraging clinical results, BEAM shares declined 7% following the announcement, likely due to concerns over weaker third-quarter results and profit-taking.
Read Full Article

Ways to Trade ACIU at MEXC

ACIU MEXC RealStocks

Own real ACIU shares through MEXC's regulated brokerage partner.

Suitable for long-term holding.

Own the actual shares
Receive dividends and voting rights
Buy fractional shares starting at $1

How to Buy AC Immune SA (ACIU) Stock on MEXC

Eligible investors can buy real shares of AC Immune SA (ACIU) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for ACIU and Place Your Order

Open the RealStocks trading page and search for ACIU. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is AC Immune SA (ACIU) stock price today?

AC Immune SA (ACIU) is currently trading at $2.14, down 5.31% ($0.12) from the previous close of $2.26. Intraday prices update in real time during regular trading hours.

2.Is ACIU stock going up or down today?

As of 2026-11-13 00:31:00, ACIU is trading at $2.14, down 5.31% ($0.12) from its previous close of $2.26. The stock has traded between $2.13 and $2.26 during today’s regular session. Past price movements do not guarantee future results.

3.What is ACIU pre-market price?

As of 2026-11-13 00:31:00, ACIU is trading at $2.32 in pre-market trading, up 2.61% ($0.06) from the previous close of $2.26. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is ACIU after-hours price?

As of 2026-11-13 00:31:00, ACIU is trading at $2.15 in after-hours trading, up 0.23% ($0.00) from the regular-session close of $2.14. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is ACIU stock trading now?

ACIU trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does ACIU sit relative to its 52-week high and low?

Over the past 52 weeks, ACIU has traded between a low of $2.02 and a high of $3.90. At $2.14, the stock is positioned 6.6% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is AC Immune SA in?

AC Immune SA (ACIU) operates in the -- sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is AC Immune SA's market capitalization and where is it listed?

AC Immune SA is listed on the NASDAQ exchange with a market capitalization of $212.77M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is ACIU valued in terms of P/E ratio and EPS?

ACIU trades at a P/E ratio of --, based on trailing-twelve-month EPS of --. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does AC Immune SA pay a dividend?

AC Immune SA pays an indicated annual cash dividend of -- per share, with a current dividend yield of --% based on the latest share price. Dividend policies are subject to change at the board's discretion.

Explore More US Stocks

Largest Market Cap

See US stocks with the highest market capitalization

Most Actively Traded

Discover today's most actively traded US stocks

Top Gainers

Browse today's leading gainers in the US stock market

Modine Manufacturing Co

MOD

Newsmax, Inc.

NMAX

Ellington Credit Company

SES

Top 5 Cryptocurrencies

Explore the cryptocurrencies with the highest market capitalization

BTC

ETH

Compliance Disclosure and Data Source

Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to ACIU, including Stocks, Tokenized Stocks, and Stock Futures.

Disclaimer

The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.

Anthropic (PRE): Win NVIDIA H200

Claim PRE points for guaranteed prizes up to $3K

Search Stocks

Popular

MOD NMAX EARN SES MTR

ACIU Stock Calculator

Estimate the value between ACIU shares and USD.

ACIU Shares to USD

ACIU Shares

ACIU

USD

1.00 ACIU shares = 2.14 USD

Calculations are estimates based on the latest available price and are for reference only.

AC Immune SA (ACIU)

Summary

Key Market Data

AC Immune SA (ACIU) Pre-Market Stock Price

AC Immune SA (ACIU) 7-Day Stock Price Change

ACIU 52-Week Price Position

What is AC Immune SA (ACIU)?

AC Immune SA Information

ACIU News

Here's Why You Should Add AURA Stock to Your Portfolio Now

Zoetis' Cytopoint Plus Gets USDA License for 75-Day Canine Itch Relief

BEAM Stock Falls 7% Despite Meeting Primary Endpoints in SCD Study

Ways to Trade ACIU at MEXC

ACIU MEXC RealStocks

How to Buy AC Immune SA (ACIU) Stock on MEXC

Frequently Asked Questions (FAQ)

Explore More US Stocks

Largest Market Cap

Most Actively Traded

Top Gainers

Top 5 Cryptocurrencies

Compliance Disclosure and Data Source

Disclaimer

Search Stocks

ACIU Stock Calculator